Technical Setup & Recent Strategic Acquisition Gives This HealthCare Tech Stock Plenty Of Bullish Catalysts
Tuesday, February 8, 2022
2021 was a huge year for merger and acquisitions, with the total value of deals not only crossing $2 trillion for the first time ever, but blowing passed it at an amazing $2.6 trillion across 7,896 transactions. The momentum has carried into 2022, as Microsoft
is buying Activision Blizzard (NASDAQ: MSFT) for $68.7 billion, Take Two (NASDQ: ATVI) is acquiring Zynga (NASDAQ: TTWO) for $12.7 billion, Optum is paying $12.6 billion for Change Healthcare (NASDAQ: ZNGA) , Frontier and Spirit (NASDAQ: CHNG) are combing in a $6.6 billion deal, and more. While those billion-dollar-buyouts make the headlines, most deals are much smaller where the amalgamations have market moving potential for the younger firms, like BioLife Sciences (NYSE: SAVE) this month signing a definitive agreement to acquire Health Box LLC, an Arizona-based orthomolecular medicine and natural health products company specialized in medicinal botanicals, micronutrients, dietary supplements, proprietary herbal blends, and apothecary style subscription services. (OTCPK: BLFE)
BioLife is an accelerator of companies and products with an initial focus on wellness, including antimicrobial technologies. Until now, the product lineup was highlighted by nanotechnology that infuses copper particles with complete coverage for a litany of potential health benefits, including healing, anti-aging, anti-inflammatory, and – particularly topical in the coronavirus age – protection against pathogens like viruses and bacteria. The company’s antimicrobial and disruptive technologies division has been expanded to accommodate a newly formed orthomolecular and natural health products division for the Health Box assets.
The all-stock acquisition of Health Box broadens the company’s scope, providing BioLife with all of Health Box’s existing inventory of efficacious supplements, super food concentrates, nutraceutical formulations, and advanced orthomolecular and natural health products. The buyout also provides BioLife with Health Box’s Intellectual Property, customers, proprietary formulations, and market research.
Health Box also specializes in hemp sourced CBD and holds the distinction of introducing the first CBD subscription health box to the U.S. market.
Together, the new management team will look to capture share in the booming global herbal supplements market that grew almost 7% annually from 2016 to 2022 to reach $86.7 billion. Trends were already in place where consumers were looking for natural alternatives to traditional pharmaceuticals that boost immunity and wellness; trends that accelerated in light of the pandemic. Leading categories along with immunity included sleep support, and brain health, as well as mood and mental wellness, with those categories growing by 30%.
Against this backdrop, the significance of adding Nika Jaksic to the BioLife board becomes crystalized. Jaksic will transition from CEO of Health Box to COO and Director at BioLife. She is a Certified Nutrition Professional who specializes in holistic nutrition and will provide customized science-based nutritional therapy and fitness planning.
Jaksic is specialized in the field of aging and developing therapeutic programs focused on improving quality of life in older populations. She has a passion for holistic nutrition and fitness and has devoted decades of her life to R&D for understanding of the relationship between aerobic fitness, nutritional therapy, meal planning, dietary guidance, and botanical supplements and the loss of brain tissue in the field of gerontology. She has done extensive research into changes in brain function and cognition that accompany normal and abnormal aging, and how providing a healthy diet, efficacious supplements and regimented fitness can assist in counteracting these ailments.
Jaksic has years of hands-on experience designing programs for the elderly, chronically ill and people with biochemical deficiencies, as well as extensive executive experience earned through senior-level positions with large corporations throughout North America. She is also recognized for her staunch advocacy for standardizing and regulating the supplements industry.
BioLife gains a lot with the Health Box acquisition by way of portfolio and management.
“[W]e will lead the way in going above and beyond the requirements of FDA regulations and the Dietary Supplement Health and Education Act of 1994, to ensure we provide only the best nutritional supplements with the highest quality standard in the market today,” said Ms. Jaksic in the
news release on the acquisition.
While shares of BLFE have pulled back in recent days, the stock still is up close to 200% from its early-November lows. From a technical perspective, a major static support level at $0.56 looks to be an area where the bulls may re-appear.
BioLife Sciences Inc. (OTCPK: BLFE) Full Corporate Write-Up:
AllPennyStocks.com Media, Inc., founded in 1999, is one of North America’s largest and most comprehensive small-cap / penny stock financial portals. With Canadian and U.S. focused penny stock features and content, the site offers information for novice investors to expert traders. Outside of the countless free content available to visitors, AllPennyStocks.com Pro (premium service) caters to traders looking for that trading edge by offering monthly stock picks, daily penny stock to watch trade ideas, market commentary and more.
As a result of its commitment to journalistic excellence and abundance of information in a particular area of equity investing (micro-cap investing) where there aren’t many credible sources of information, AllPennyStocks.com continues to have one of the largest audiences of micro-cap investors on the internet.
Copyright © 2022 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
AllPennyStocks.com has been compensated nineteen thousand dollars by the company for its efforts in presenting the BLFE profile on its web site and distributing it to its database of subscribers as well as other services. For a complete disclaimer, investors are encouraged to click here: https://www.allpennystocks.com/spotlight/1079/biolife-sciences-inc
Other Penny Stock Movers
EdTech Provider Gains Traction in Mexico
Consumer Sentiment Falls Sharply in the U.S. Amid Higher Inflation Expectations
Major ESG Index Rating Upgrade for Consumer Group